These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23150447)

  • 1. Isolation and characterization of murine multipotent lung stem cells.
    Gadepalli VS; Vaughan C; Rao RR
    Methods Mol Biol; 2013; 962():183-91. PubMed ID: 23150447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch.
    Ouadah Y; Rojas ER; Riordan DP; Capostagno S; Kuo CS; Krasnow MA
    Cell; 2019 Oct; 179(2):403-416.e23. PubMed ID: 31585080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
    Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
    Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult lung stem cells and their contribution to lung tumourigenesis.
    Asselin-Labat ML; Filby CE
    Open Biol; 2012 Aug; 2(8):120094. PubMed ID: 22977734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells.
    Moon JH; Kwon S; Jun EK; Kim A; Whang KY; Kim H; Oh S; Yoon BS; You S
    Biochem Biophys Res Commun; 2011 Aug; 412(1):175-81. PubMed ID: 21810410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
    Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
    Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer stem cells, p53 mutations and MDM2.
    Gadepalli VS; Deb SP; Deb S; Rao RR
    Subcell Biochem; 2014; 85():359-70. PubMed ID: 25201204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.
    Loizou E; Banito A; Livshits G; Ho YJ; Koche RP; Sánchez-Rivera FJ; Mayle A; Chen CC; Kinalis S; Bagger FO; Kastenhuber ER; Durham BH; Lowe SW
    Cancer Discov; 2019 Jul; 9(7):962-979. PubMed ID: 31068365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
    Bao L; Cardiff RD; Steinbach P; Messer KS; Ellies LG
    Breast Cancer Res; 2015 Oct; 17(1):137. PubMed ID: 26467658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 switches off pluripotency on differentiation.
    Lin T; Lin Y
    Stem Cell Res Ther; 2017 Feb; 8(1):44. PubMed ID: 28241890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse induced glioma-initiating cell models and therapeutic targets.
    Kondo T
    Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.
    Sullivan JP; Minna JD; Shay JW
    Cancer Metastasis Rev; 2010 Mar; 29(1):61-72. PubMed ID: 20094757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRP1-positive lung cancer cells possess tumor-initiating properties.
    Jimenez-Hernandez LE; Vazquez-Santillan K; Castro-Oropeza R; Martinez-Ruiz G; Muñoz-Galindo L; Gonzalez-Torres C; Cortes-Gonzalez CC; Victoria-Acosta G; Melendez-Zajgla J; Maldonado V
    Oncol Rep; 2018 Jan; 39(1):349-357. PubMed ID: 29138851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of murine multipotent lung stem cells.
    Hegab AE; Kubo H; Fujino N; Suzuki T; He M; Kato H; Yamaya M
    Stem Cells Dev; 2010 Apr; 19(4):523-36. PubMed ID: 19848595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.
    Sellers ZP; Schneider G; Bujko K; Suszynska M; Pedziwiatr D
    Stem Cell Rev Rep; 2017 Oct; 13(5):603-610. PubMed ID: 28624968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
    Xu Y; Xu Z; Li Q; Guo L; Wang Y; Zhou J; Wang G; Liu Y
    J Immunol Res; 2019; 2019():7478538. PubMed ID: 31781681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
    Rizo A; Vellenga E; de Haan G; Schuringa JJ
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R210-9. PubMed ID: 16987886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent mechanisms in pluripotent stem cells and cancer: implications for stem cell engineering.
    Mooney BM; Raof NA; Li Y; Xie Y
    Biotechnol J; 2013 Apr; 8(4):408-19. PubMed ID: 23418009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.